Tuesday, November 30, 2021
6:00 p.m. to 7:00 p.m.
Virtual

Register Here

Educational Objectives

After completion of this activity, Pharmacists will be able to:

• Examine the pathophysiology of Waldenström macroglobulinemia and its connection to the use of new and emerging drug therapies
• Apply knowledge of clinical guidelines to treatment selection in patients with Waldenström macroglobulinemia
• Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia

After completion of this activity, Pharmacy Technicians will be able to:

• Outline clinical presentation and complications of Waldenström macroglobulinemia
• Review oral oncolytics used in the treatment of Waldenström macroglobulinemia
• List common adverse effects associated with therapies used for Waldenström macroglobulinemia

Speaker

Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy

Registration Rates

VPhA Member: FREE (Registration is still required to attend)
Non-Member: FREE (Registration is still required to attend)

ChapterMeeting_Macroglobulinemia_Nov30

Learn more at www.pharmacytimes.org